BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
86 hedge funds and large institutions have $148M invested in BioSpecifics Technologies Corp. in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 8 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 21
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
4% more funds holding
Funds holding: 83 → 86 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $152M → $148M (-$4.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$5.28M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.49M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.26M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$3M |
| 5 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$2.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$7.42M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$2.42M |
| 3 |
Two Sigma Investments
New York
|
-$1.51M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$1.14M |
| 5 |
Renaissance Technologies
New York
|
-$690K |
BSTC Hedge Fund Activity: Q3 2015 in Review
86 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2015, worth a combined $148M — down 3.2% from $152M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new BSTC positions and 8 closed out — a net gain of 3 holders — while 42 added to existing stakes and 21 trimmed.
The largest buyer was Allianz Asset Management, adding an estimated $5.28M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.42M sold.
- 86 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2015, up from 83 in Q2 2015.
- Funds reported $148M of BioSpecifics Technologies Corp. stock for Q3 2015, down 3.2% quarter-over-quarter.
- 11 funds opened new BioSpecifics Technologies Corp. positions in Q3 2015 and 8 closed out, a net change of +3 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q3 2015 was Allianz Asset Management, an estimated $5.28M added.
- The largest BioSpecifics Technologies Corp. seller in Q3 2015 was Franklin Resources, an estimated $7.42M sold.
Based on aggregated 13F filings for Q3 2015.